Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile Using Historical Data
Jonathan D. Mosley(Tennessee Department of Health), Dan M. Roden(Garvan Institute of Medical Research), Jennifer A. Pacheco(University of Arizona), David R. Crosslin(Tulane University), Quinn S. Wells(Vanderbilt University), Catherine A. McCarty(University of Minnesota, Duluth), Gail P. Jarvik(University of Washington Medical Center), Christopher G. Chute(Johns Hopkins University), Iftikhar J. Kullo(Medical College of Wisconsin), Joshua C. Denny(National Institutes of Health), Murray H. Brilliant(Marshfield Clinic), Sara L. Van Driest(Vanderbilt University Medical Center), Peggy Peissig(Pew Research Center), Eric B. Larson(University of Washington), Lisa Bastarache(Vanderbilt University Medical Center), James G. Linneman(Marshfield Clinic), Will Thompson, Christian M. Shaffer(Vanderbilt University Medical Center), Todd L. Edwards(Nashville VA Medical Center)
Cited by 7
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics
|Nature Communications|2018|1.3k